Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$152K Hold
5,410
﹤0.01% 2736
2016
Q3
$148K Hold
5,410
﹤0.01% 2723
2016
Q2
$118K Sell
5,410
-2,361
-30% -$51.5K ﹤0.01% 2741
2016
Q1
$174K Hold
7,771
﹤0.01% 2616
2015
Q4
$215K Hold
7,771
﹤0.01% 2510
2015
Q3
$200K Buy
7,771
+248
+3% +$6.38K ﹤0.01% 2536
2015
Q2
$186K Hold
7,523
﹤0.01% 2596
2015
Q1
$190K Sell
7,523
-284
-4% -$7.17K ﹤0.01% 2511
2014
Q4
$183K Hold
7,807
﹤0.01% 2543
2014
Q3
$178K Hold
7,807
﹤0.01% 2490
2014
Q2
$191K Sell
7,807
-1,269
-14% -$31K ﹤0.01% 2469
2014
Q1
$192K Buy
9,076
+1,273
+16% +$26.9K ﹤0.01% 2479
2013
Q4
$186K Sell
7,803
-275
-3% -$6.55K ﹤0.01% 2428
2013
Q3
$173K Hold
8,078
﹤0.01% 2520
2013
Q2
$161K Buy
+8,078
New +$161K ﹤0.01% 2312

Other funds holding QGENF

BlackRock Group's QGENF Position: Q4 2016 in Review

BlackRock Group held its QIAGEN NV (QGENF) position steady in Q4 2016 at 5,410 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

BlackRock Group first reported a position in QGENF in Q2 2013 and has held it in 15 quarters since. The position peaked at $215K in Q4 2015. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • BlackRock Group held 5,410 shares of QIAGEN NV worth $152K as of Q4 2016.
  • BlackRock Group left its QIAGEN NV share count unchanged in Q4 2016.
  • QIAGEN NV made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2736 holding.
  • BlackRock Group first reported a position in QIAGEN NV in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's QIAGEN NV position peaked at $215K in Q4 2015.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.